Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 26;10(9):1454.
doi: 10.3390/children10091454.

State of the Evidence for Use of Psychotropic Medications in School-Age Youth

Jeffrey D Shahidullah  1 , Holly Roberts  2 , John Parkhurst  3 , Rachel Ballard  3 , Jennifer A Mautone  4 , John S Carlson  5
Affiliations
Review

State of the Evidence for Use of Psychotropic Medications in School-Age Youth

Jeffrey D Shahidullah et al. Children (Basel). .

Abstract

Psychotropic medications are commonly prescribed to school-aged youth for the management of mental health concerns. This paper describes the current state of evidence for psychotropic medications in school-aged youth. More specifically, the following sections summarize relevant medication research trials and practice parameters pertaining to psychotropic medication prescribing as well as the specific medications indicated for a range of commonly presenting disorders and symptom clusters in school-aged youth. For each of these disorders and symptom clusters, key findings pertaining to the current state of science and practice are highlighted for the purpose of offering patients, clinicians, researchers, and policymakers with nuanced considerations for the role of psychopharmacology within the context of a larger "whole-child" approach to care that relies on the collaboration of providers and services across systems of care to promote optimal child and family health and wellness. The paper concludes with a discussion about supporting the use of medication treatments in schools, including considerations for ensuring effective family-school-health system collaboration to best meet youth mental health needs.

Keywords: mental health; pediatric psychopharmacology; psychotropic medications; school age youth.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Bitsko R.H., Holbrook J.R., Ghandour R.M., Blumberg S.J., Visser S.N., Perou R., Walkup J.T. Epidemiology and impact of health care provider-diagnosed anxiety and depression among US children. J. Dev. Behav. Pediatr. 2018;39:395–403. doi: 10.1097/DBP.0000000000000571. - DOI - PMC - PubMed
    1. Cree R.A., Bitsko R.H., Robinson L.R., Holbrook J.R., Danielson M.L., Smith C., Kaminski J.W., Kenney M.K., Peacok G. Health care, family, and community factors associated with mental, behavioral, and developmental disorders and poverty among children aged 2–8 Years—United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 2018;67:1377–1383. doi: 10.15585/mmwr.mm6750a1. - DOI - PMC - PubMed
    1. Bitsko R.H., Claussen A.H., Lichstein J., Black J., Everett Jones S., Danielson M.L., Hoenig J.M., Davis Jack S.P., Brody D.J. Mental health surveillance among children—United States, 2013–2019. MMWR Suppl. 2022;71:1–42. doi: 10.15585/mmwr.su7102a1. - DOI - PMC - PubMed
    1. Lebrun-Harris L.A., Ghandour R.M., Kogan M.D., Warren M.D. Five-year trends in US children’s health and well-being, 2016–2020. JAMA Pediatr. 2022;176:e220056. doi: 10.1001/jamapediatrics.2022.0056. - DOI - PMC - PubMed
    1. Racine N., McArthur B.A., Cooke J.E., Eirich R., Zhu J., Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: A meta-analysis. JAMA Pediatr. 2021;175:1142–1150. doi: 10.1001/jamapediatrics.2021.2482. - DOI - PMC - PubMed

LinkOut - more resources